Correction: Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial
Stem Cell Res Ther. 2024 Feb 14;15(1):40.
doi: 10.1186/s13287-024-03663-x.
1 Department of Cardiovascular Medicine, TAHA Clinical Trial Group, School of Medicine, Shiraz University of Medical Sciences, Zand Street, Shiraz, 71344-1864, Iran. attar_armin@yahoo.com.
2 School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
3 Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
4 Department of Cardiovascular Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
5 Hematopathology and Molecular Pathology Service, Department of Pathology, Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, 71344-1864, Iran.
6 Department of Biostatistics, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
7 Hematopathology and Molecular Pathology Service, Department of Pathology, Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, 71344-1864, Iran. monabati.am@gmail.com.
8 Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran. monabati.am@gmail.com.